R
Rallybio Corporation (RLYB)
NCM – Real vaqt narxi. Valyuta: USD
14.03
+0.03 (0.21%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
14.03
+0.03 (0.21%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Rallybio Corporation, klinik bosqichdagi biotexnologiya kompaniyasi, og'ir va kam uchraydigan kasalliklardan aziyat chekayotgan bemorlar uchun hayotni o'zgartiruvchi davolash usullarini ishlab chiqish va tijoratlashtirish bilan shug'ullanadi. Uning asosiy mahsulot nomzodi RLYB116, to'yintirish komponenti 5 (C5) ning ingibitori bo'lib, to'yintirishni tartibga solishning bir qator kasalliklarini davolash uchun mo'ljallangan, bu birinchi bosqich sinovlarini yakunlagan; va RLYB332, preklinik antitel, og'ir anemiya, samarasiz eritropoez va temir ortiqcha yuklanishini davolash uchun. Kompaniya kam uchraydigan kasalliklar uchun yangi antitel asosidagi terapevtik vositalarni kashf qilish, ishlab chiqish va tijoratlashtirish bo'yicha AbCellera bilan strategik ittifoqqa ega, shuningdek, homilaning va chaqaloqlarning alloimmun trombotsitopeniyasi xavfi ostida bo'lgan homilador ayollar uchun terapevtik yechimlarni taqdim etish bo'yicha Johnson & Johnson bilan hamkorlik shartnomasiga ega. Rallybio Corporation 2018 yilda tashkil etilgan va shtab-kvartirasi Nyu-Xeyven, Konnektikutda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Martin W. MacKay Ph.D. | Co-Founder & Chairman |
| Dr. Stephen Uden M.D., MBBS | Co-Founder, President, CEO & Director |
| Mr. Jonathan I. Lieber M.B.A. | CFO & Treasurer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-05 | RW | d109079drw.htm |
| 2026-05-04 | 8-K | d19625d8k.htm |
| 2026-04-24 | S-4/A | d109079ds4a.htm |
| 2026-03-31 | 8-K | rlyb-20260331.htm |
| 2026-03-17 | S-4 | d109079ds4.htm |
| 2026-03-16 | 10-K | rlyb-20251231.htm |
| 2026-03-02 | 8-K | d108429d8k.htm |
| 2026-03-02 | 425 | d108429d425.htm |
| 2026-01-29 | 8-K | rlyb-20260126.htm |
| 2026-01-02 | DEF 14A | ny20061662x2_def14a.htm |